av/metropolis-healthcare--big.svg

COM:METROPOLISINDIA

Metropolis Healthcare

  • Stock

Last Close

2,061.85

25/11 05:19

Market Cap

105.44B

Beta: -

Volume Today

50.76K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
148.50M
-
176.59M
18.91%
236.45M
33.90%
252.51M
6.80%
324.75M
28.60%
458.27M
41.12%
478.49M
4.41%
average payables
343.57M
-
356.23M
3.68%
390.94M
9.74%
639.42M
63.56%
977.95M
52.94%
1.07B
9.29%
986.45M
7.71%
average receivables
739.70M
-
1.48B
99.44%
1.34B
8.83%
book value per share
55.35
-
65.12
17.66%
83.58
28.34%
83.82
0.30%
104.26
24.38%
138.81
33.14%
173.23
24.80%
193.04
11.43%
capex per share
-3.32
-
-3.34
0.73%
-4.01
19.88%
-4.76
18.62%
-7.21
51.64%
-5.55
22.98%
-5.99
7.92%
-10.28
71.53%
capex to depreciation
-1.00
-
-0.96
4.11%
-1.05
8.59%
-1.18
13.10%
-0.92
22.07%
-0.62
33.26%
-0.48
21.19%
-0.59
21.64%
capex to operating cash flow
-0.18
-
-0.16
10.82%
-0.19
17.37%
-0.26
37.58%
-0.17
36.06%
-0.11
32.58%
-0.12
6.63%
-0.21
75.95%
capex to revenue
-0.04
-
-0.03
13.36%
-0.03
1.47%
-0.03
1.05%
-0.04
35.43%
-0.03
33.02%
-0.02
11.90%
-0.05
83.63%
cash per share
25.37
-
34.92
37.61%
30.65
12.21%
18.87
38.44%
41.03
117.41%
82.59
101.30%
35.30
57.26%
23.50
33.43%
days of inventory on hand
43.95
-
36.77
16.33%
50.34
36.90%
52.50
4.30%
41.72
20.54%
56.88
36.35%
64.88
14.07%
62.64
3.45%
days payables outstanding
92.59
-
93.44
0.91%
83.96
10.15%
86.18
2.65%
145.37
68.68%
155.08
6.67%
131.02
15.51%
132.16
0.87%
days sales outstanding
54.12
-
43.71
19.22%
38.75
11.36%
debt to assets
0.01
-
0.00
84.86%
0.00
23.00%
0.03
2,224.49%
0.09
175.62%
0.11
26.06%
0.25
121.31%
0.18
28.29%
debt to equity
0.02
-
0.00
83.00%
0.00
38.24%
0.04
2,300.41%
0.13
199.95%
0.16
24.70%
0.43
168.85%
0.27
36.90%
dividend yield
0.02
-
0.00
99.63%
0.01
17,541.47%
0.01
25.37%
0.01
55.17%
0.00
42.41%
0.00
9.67%
0.01
63.08%
earnings yield
0.02
-
0.02
34.33%
0.02
0.60%
0.03
16.77%
0.02
21.25%
0.02
18.71%
0.02
28.15%
0.02
8.71%
enterprise value
48.12B
-
47.39B
1.51%
47.21B
0.38%
47.59B
0.81%
64.09B
34.67%
111.34B
73.73%
107.27B
3.66%
65.88B
38.58%
enterprise value over ebitda
35.71
-
28.78
19.42%
26.17
9.05%
23.15
11.54%
29.21
26.15%
37.41
28.08%
29.79
20.37%
21.71
27.14%
ev to operating cash flow
52.63
-
46.57
11.52%
45.42
2.47%
52.79
16.22%
29.81
43.53%
44.71
49.99%
42.35
5.28%
26.66
37.04%
ev to sales
10.12
-
8.70
14.03%
7.34
15.68%
6.26
14.64%
7.49
19.60%
11.16
49.02%
8.73
21.74%
5.74
34.30%
free cash flow per share
14.83
-
17.16
15.69%
16.93
1.32%
13.30
21.46%
35.61
167.73%
43.37
21.79%
43.52
0.34%
37.98
12.71%
free cash flow yield
0.02
-
0.02
15.69%
0.02
1.32%
0.01
21.46%
0.03
100.07%
0.02
30.20%
0.02
10.47%
0.03
42.35%
graham net net
6.66
-
1.88
71.72%
12.40
558.21%
-5.09
141.02%
-1.77
65.28%
50.16
2,940.61%
-63.66
226.92%
-54.08
15.04%
graham number
137.80
-
173.24
25.72%
196.85
13.63%
213.04
8.22%
243.90
14.49%
335.17
37.42%
403.97
20.53%
348.17
13.81%
income quality
0.72
-
0.64
11.24%
0.65
1.90%
0.48
25.46%
1.27
163.68%
1.02
20.01%
0.86
15.29%
1.32
52.63%
intangibles to total assets
0.09
-
0.19
107.15%
0.18
4.92%
0.18
2.79%
0.16
14.57%
0.12
21.10%
0.53
329.00%
0.55
3.60%
interest coverage
141.27
-
358.30
153.62%
134.30
62.52%
349.50
160.23%
21.59
93.82%
32.34
49.81%
15.04
53.51%
8.00
46.82%
interest debt per share
1.09
-
0.26
75.76%
0.39
47.91%
3.67
837.13%
14.95
307.57%
23.58
57.79%
77.86
230.14%
57.27
26.44%
inventory turnover
8.31
-
9.93
19.52%
7.25
26.95%
6.95
4.12%
8.75
25.85%
6.42
26.66%
5.63
12.33%
5.83
3.58%
invested capital
0.02
-
0.00
83.00%
0.00
38.24%
0.04
2,300.41%
0.13
199.95%
0.16
24.70%
0.43
168.85%
0.27
36.90%
market cap
48.34B
-
47.63B
1.46%
47.63B
0%
47.93B
0.61%
64.49B
34.57%
114.09B
76.89%
104.14B
8.72%
63.91B
38.64%
net current asset value
1.23B
-
1.14B
7.44%
1.99B
74.69%
1.72B
13.69%
1.70B
1.20%
3.12B
83.61%
-2.49B
179.78%
-2.08B
16.40%
net debt to ebitda
-0.16
-
-0.15
9.13%
-0.24
58.71%
-0.16
31.02%
-0.18
12.86%
-0.92
399.71%
0.87
194.18%
0.65
25.03%
net income per share
15.25
-
20.48
34.33%
20.61
0.60%
24.06
16.77%
25.36
5.38%
35.97
41.84%
41.87
16.40%
27.91
33.34%
operating cash flow per share
18.15
-
20.50
12.95%
20.94
2.14%
18.06
13.79%
42.82
137.16%
48.92
14.25%
49.51
1.20%
48.27
2.51%
payables turnover
3.94
-
3.91
0.91%
4.35
11.29%
4.24
2.58%
2.51
40.72%
2.35
6.26%
2.79
18.36%
2.76
0.86%
receivables turnover
6.74
-
8.35
23.80%
9.42
12.82%
research and ddevelopement to revenue
return on tangible assets
0.21
-
0.24
13.97%
0.23
3.38%
0.27
13.44%
0.20
24.63%
0.21
3.61%
0.30
44.04%
0.21
29.10%
revenue per share
94.41
-
109.76
16.26%
129.68
18.15%
152.22
17.38%
170.45
11.97%
196.02
15.00%
240.11
22.50%
224.29
6.59%
roe
0.28
-
0.31
14.16%
0.25
21.62%
0.29
16.43%
0.24
15.27%
0.26
6.54%
0.24
6.73%
0.14
40.18%
roic
0.26
-
0.29
12.25%
0.27
6.84%
0.28
5.45%
0.21
26.46%
0.20
2.17%
0.16
22.66%
0.11
27.55%
sales general and administrative to revenue
0.06
-
0.06
6.79%
0.06
3.17%
0.05
20.63%
0.04
7.23%
0.04
3.66%
0.07
62.67%
0.12
68.55%
shareholders equity per share
55.35
-
65.12
17.66%
83.58
28.34%
83.82
0.30%
104.26
24.38%
138.81
33.14%
173.23
24.80%
193.04
11.43%
stock based compensation to revenue
0.00
-
0.00
3,167.55%
0.00
54.89%
0.00
27.32%
0.01
822.91%
0.01
28.48%
0.00
95.55%
tangible asset value
2.58B
-
2.47B
4.21%
3.34B
35.24%
3.18B
4.77%
4.07B
27.85%
5.83B
43.42%
721.84M
87.62%
1.61B
123.29%
tangible book value per share
51.20
-
49.76
2.80%
67.30
35.24%
63.70
5.35%
80.99
27.14%
114.57
41.47%
14.11
87.68%
31.48
123.12%
working capital
1.34B
-
1.33B
0.82%
2.10B
57.54%
1.80B
14.15%
2.28B
26.27%
4.05B
77.74%
915.72M
77.36%
377.63M
58.76%

All numbers in (except ratios and percentages)